Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
1.070
-0.060 (-5.31%)
At close: Feb 27, 2026, 4:00 PM EST
1.090
+0.020 (1.87%)
After-hours: Feb 27, 2026, 5:10 PM EST
Hyperfine Revenue
Hyperfine had revenue of $3.44M in the quarter ending September 30, 2025, a decrease of -5.65%. This brings the company's revenue in the last twelve months to $10.59M, down -20.10% year-over-year. In the year 2024, Hyperfine had annual revenue of $12.89M with 16.84% growth.
Revenue (ttm)
$10.59M
Revenue Growth
-20.10%
P/S Ratio
9.82
Revenue / Employee
$95,414
Employees
111
Market Cap
103.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.89M | 1.86M | 16.84% |
| Dec 31, 2023 | 11.03M | 4.22M | 61.90% |
| Dec 31, 2022 | 6.81M | 5.32M | 355.48% |
| Dec 31, 2021 | 1.50M | 1.20M | 408.84% |
| Dec 31, 2020 | 294.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Treace Medical Concepts | 218.88M |
| Xtant Medical Holdings | 133.08M |
| Neuronetics | 129.87M |
| AVITA Medical | 71.61M |
| LENSAR | 59.14M |
| Apyx Medical | 47.90M |
| MaxCyte | 34.42M |
| Baird Medical Investment Holdings | 31.86M |
HYPR News
- 4 weeks ago - Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System's Enhanced Stroke Detection Capabilities - Business Wire
- 5 weeks ago - Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics - Business Wire
- 6 weeks ago - Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents - Business Wire
- 6 weeks ago - Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 7 weeks ago - Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care - Business Wire
- 2 months ago - Hyperfine Announces Regulatory Approval of the Swoop® System in India - Business Wire
- 2 months ago - Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System - Business Wire
- 3 months ago - Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - Business Wire